Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy

Overview of attention for article published in International Journal of General Medicine, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus: 1 Google+ user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Google+ Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report

Article in Frontiers in Oncology (January 2023)

Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols.

Article in International Journal of Hematology-Oncology and Stem Cell Research (April 2020)

Bortezomib‐based four‐drug induction does induce a response in advanced relapsed ALL but cure remains elusive

Article in Pediatric Blood & Cancer (December 2019)